Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
Displaying 3101 - 3120 of 5152
Sony BMG Music Entertainment., In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
062-3019
Dissenting Statement of Commissioner Jon Leibowitz, In the Matter of DirectRevenue LLC
Date
By
Jon Leibowitz, Former Chairman
Matter Number
052 3131
Concurring Statement of Commissioner Jon Leibowitz Regarding the Staff Report: "Broadband Connectivity Competition Policy"
Date
By
Jon Leibowitz, Former Chairman
Matter Number
V070000
InPhonic, Inc., In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
062 3066
Soyo, Inc., In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
062-3094
Richardson, Thomas E., d/b/a Mid-South Distributors
Type of Action
Federal
Last Updated
FTC Matter/File Number
062 3221
X070014
Foster, Paul L., Western Refining, Inc., and Giant Industries, Inc.
Type of Action
Federal
Last Updated
FTC Matter/File Number
061 0259
Debt Solutions, Inc., also d/b/a DSI Financial, Inc.; et al.
Type of Action
Federal
Last Updated
FTC Matter/File Number
052 3002
Actavis Group hf. and Abrika Pharmaceuticals, Inc., In the Matter of
The Commission prevented a merger-to-monopoly in the sale of generic isradipine capsules by challenging the proposed $235 million purchase of Abrika Pharmaceuticals, Inc., by the Actavis Group, an international generic pharmaceuticals company. To maintain competition in the market for this important generic drug, used to lower blood pressure and to treat hypertension, ischemia, and depression, the consent order requires the divestiture of all rights and assets necessary to produce, market, and sell generic isradipine to Cobalt Laboratories, Inc.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0710063
Displaying 3101 - 3120 of 5152